The Neuroprotective Effects of Histamine H3 Receptor Antagonist E177 on Pilocarpine-Induced Status Epilepticus in Rats.

Abstract

Epilepsy is a multifaceted neurological disorder which severely affects neuronal function. Some patients may experience status epilepticus (SE), a life-threatening state of ongoing seizure activity linked to cognitive dysfunction, necessitating an immediate intervention. The potential of histamine H3 receptors in several neuropsychiatric diseases including epilepsy is well recognized. In the current study, we aimed to explore the effect of H3R antagonist E177 on prevention and termination of pilocarpine (PLC)-induced SE in rats as well as evaluating the effects of E177 on the levels of oxidative stress in hippocampus tissues. The results showed that the survival rate of animals pretreated with E177 (5 and 10 mg/kg, intraperitoneal (i.p.)) was significantly increased during the first hour of observation, and animals were protected from SE incidence and showed a prolonged average of latency to the first seizure when compared with animals pretreated with PLC (400 mg/kg, i.p.). Moreover, the protective effect of E177 (10 mg/kg) on SE was partially reversed when rats were co- administered with H3R agonist R-(α)-methylhistamine (RAM) and with the H2R antagonist zolantidine (ZOL), but not with the H1R antagonist pyrilamine (PYR). Furthermore, pretreatment with E177 (5 and 10 mg/kg) significantly decreased the abnormal levels of malondialdehyde (MDA), and increased levels of glutathione (GSH) in the hippocampal tissues of the treated rats. However, E177 failed to modulate the levels of catalase (CAT), superoxide dismutase (SOD), or acetylcholine esterase activity (AChE). Our findings suggest that the newly developed H3R antagonist E177 provides neuroprotection in a preclinical PLC-induced SE in rats, highlighting the histaminergic system as a potential therapeutic target for the therapeutic management of SE.

• Authors: Alaa Alachkar, Sheikh Azimullah, Shreesh K Ojha, Rami Beiram, Dorota Łażewska, Katarzyna Kieć-Kononowicz, Bassem Sadek
• Journal: Molecules (Basel, Switzerland) (Molecules) Vol. 24 Issue 22 (Nov 14 2019) ISSN: 1420-3049 [Electronic] Switzerland
• PMID: 31739417 (Publication Type: Journal Article)

Chemical References

• Histamine H3 Antagonists
• Neuroprotective Agents
• Pilocarpine
• Catalase
• Superoxide Dismutase

Topics

• Animals
• Catalase (metabolism)
• Disease Models, Animal
• Histamine H3 Antagonists (therapeutic use)
• Male
• Neuroprotective Agents (therapeutic use)
• Pilocarpine (toxicity)
• Rats
• Rats, Wistar
• Status Epilepticus (chemically induced, drug therapy, metabolism)
• Superoxide Dismutase (metabolism)